Quoin Pharmaceuticals Stock (NASDAQ:QNRX)
Previous Close
$0.73
52W Range
$0.60 - $12.00
50D Avg
$1.16
200D Avg
$3.88
Market Cap
$731.32K
Avg Vol (3M)
$632.44K
Beta
1.95
Div Yield
-
QNRX Company Profile
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.
QNRX Performance
Peer Comparison
Ticker | Company |
---|---|
CDIO | Cardio Diagnostics Holdings, Inc. |
BDRX | Biodexa Pharmaceuticals Plc |
VRAX | Virax Biolabs Group Limited |
UNCY | Unicycive Therapeutics, Inc. |
BWV | Onconetix, Inc. |
PXMD | PaxMedica, Inc. Common Stock |
REVB | Revelation Biosciences, Inc. |
NRBO | NeuroBo Pharmaceuticals, Inc. |
HILS | Tharimmune, Inc. |
ALLR | Allarity Therapeutics, Inc. |